Close

Denali Therapeutics Announces Closing of a $316 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Oct 24, 2022 04:30PM
Denali Therapeutics Announces Closing of a $316 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Oct 24, 2022 04:30PM
Denali Therapeutics (DNLI) Prices 10.38M Share Offering at $26.50/sh Oct 20, 2022 03:39AM
Denali Therapeutics Announces Pricing of $275 Million Public Offering of Common Stock Oct 19, 2022 09:19PM
Denali Therapeutics Announces Pricing of $275 Million Public Offering of Common Stock Oct 19, 2022 09:19PM


Oct 18, 2022 04:41PM Denali Therapeutics (DNLI) Announces Proposed $250M Offering of Common Stock
Oct 18, 2022 04:40PM Denali Therapeutics Announces Proposed Offering of Common Stock
Oct 18, 2022 04:40PM Denali Therapeutics Announces Proposed Offering of Common Stock
Jan 29, 2019 06:06AM Cantor Fitzgerald Downgrades Denali Therapeutics Inc. (DNLI) to Neutral
Nov 15, 2018 04:21AM Cantor Fitzgerald Starts Denali Therapeutics Inc. (DNLI) at Overweight